EBITDA: Income before interest, taxes, depreciation and amortization.
Mustang Bio, Inc. (MBIO) had EBITDA of $-1.17M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.07M |
|
-- |
|
-- |
|
$1.17M |
|
$-1.17M |
|
$0.10M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.07M |
|
$-1.17M |
|
|
EBITDA |
$-1.17M |
6.73M |
|
6.73M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$15.61M |
|
-- |
|
-- |
|
$15.61M |
|
$7.92M |
|
-- |
|
$0.15M |
|
$8.07M |
|
$7.54M |
|
$7.54M |
|
$7.54M |
|
7.58M |
|
| Cash Flow Statement Financials | |
$-1.98M |
|
$0.00M |
|
$-0.14M |
|
$17.27M |
|
$15.15M |
|
$-2.12M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.21% |
|
-14.21% |
|
-6.87% |
|
-14.21% |
|
$1.00 |
|
$-0.29 |
|
$-0.29 |
|